The effect of epidemics on pregnant women and newborns has often been neglected, so what do we know about the effects of COVID-19 in pregnancy and newborns?
As vaccines and other treatments are developed, should pregnant women also be included in clinical trials?
In low- and middle-income countries, disruption of essential maternity and newborn services may erode many of the gains made in maternal and child health over the past two decades.
Jill will reflect on her journey towards leadership over her career, in the context of the changing understanding about effective leadership, gender issues in leadership, and her experiences of the Homeward Bound Women in STEMM leadership program during 2019
In the era of Covid-19, the imperative to manage our finite healthcare resources has become greater than ever. RCH became a Choosing Wisely Champion Hospital in 2019 and is committed to providing the safest, high-quality, high-value care for our patients. Through Choosing Wisely, the RCH is part of a worldwide campaign challenging clinicians to think differently about the way we provide care, and to challenge the status quo when what we might normally do is no longer adding value to patient outcomes.
The exit strategy for COVID-19 is a vaccine. To stop this pandemic we may need to vaccinate a significant proportion of the entire global population of 7 billion people. Where are we up to with vaccine development? Who gets vaccinated? How to communicate the benefits of a novel, fast tracked vaccine when misinformation is already spreading.
We are living through the greatest disruption of the post-war era; what is likely to be the defining historical period of our lives. This may be the end of the ‘good times’ for the world, but it has been a long time coming, and Covid-19 is simply an accelerant. Therefore, it is important now to focus on what has to be done, for all that stands between us and disaster is good government.
COVID-19 has resulted in a flurry of high-stakes decision-making, at a public health level and an individual patient level, with significant impacts on how children are cared for, and how staff work. Many of these decisions have ethical dimensions.
Blood-clotting complications are rapidly emerging as a significant part of the pathogenesis of COVID-19. There are reports of otherwise well people with COVID-10 having strokes, pulmonary emboli and heart attacks, and children with inflammation of their blood vessels. In recent weeks series of cases of a multi-system inflammatory condition, some resembling Kawasaki disease, have been reported in children in Europe, UK and USA.
COVID-19 is almost always a mild disease in children. Adults are much more likely to become very unwell or die than children. Why is this so?
Data from around the world consistently shows that COVID-19 is essentially a mild disease in children. However, the indirect effects of COVID-19 may have a more profound effect than the direct effects of the infection.
We will hear from 3 speakers on the global and clinical aspects, and the broader social, education and wellbeing impact of COVID-19 on children.
Spleen Australia was established as the Spleen registry in 2003 by Denis Spelman and Penny Jones, from the Alfred Hospital. It is a registry and clinical service for people of all ages who do not have a functioning spleen, and aims to reduce the incidence of overwhelming sepsis.
